317 related articles for article (PubMed ID: 19937027)
1. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.
Golfieri R; Giampalma E; Renzulli M; Cioni R; Bargellini I; Bartolozzi C; Breatta AD; Gandini G; Nani R; Gasparini D; Cucchetti A; Bolondi L; Trevisani F;
Br J Cancer; 2014 Jul; 111(2):255-64. PubMed ID: 24937669
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study.
Hai L; Liu S; Ma L; Ding X; Bai X; Luo X
Technol Cancer Res Treat; 2024; 23():15330338241250315. PubMed ID: 38773767
[No Abstract] [Full Text] [Related]
4. Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month.
Chiu SH; Lin HH; Feng AC; Lo CH; Hsieh CB; Chen PK; Chang WC
Eur J Radiol; 2024 Jan; 170():111266. PubMed ID: 38185027
[TBL] [Abstract][Full Text] [Related]
5. Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning.
Valle LGM; Cunha MJS; Schmid BP; Falsarella PM; Rezende MB; Felga GEG; Ogawa RE; Garcia RG; Affonso BB; Nasser F; Galastri FL
Einstein (Sao Paulo); 2023; 21():eAO0307. PubMed ID: 37909650
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transarterial bland embolization and drug-eluting beads transarterial chemoembolization for very early and early hepatocellular carcinoma not amenable for surgery or ablation: a single center retrospective data analysis.
Cathomas M; Mueller F; Mertineit N; Baumgartner I; Candinas D; Berzigotti A; Maurer MH; Lachenmayer A
J Gastrointest Oncol; 2023 Oct; 14(5):2167-2177. PubMed ID: 37969817
[TBL] [Abstract][Full Text] [Related]
7. Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor Liver Transplantation.
Lim WX; Sim KS; Chen CL; Ou HY; Yu CY; Cheng YF
Transplant Proc; 2024 Apr; 56(3):596-601. PubMed ID: 38472083
[TBL] [Abstract][Full Text] [Related]
8. Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma.
Shirono T; Iwamoto H; Niizeki T; Shimose S; Kajiwara A; Suzuki H; Kamachi N; Noda Y; Okamura S; Nakano M; Kuromatsu R; Murotani K; Koga H; Torimura T
Hepatol Commun; 2022 Sep; 6(9):2594-2604. PubMed ID: 35656864
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.
Lee EW; Khan S
Clin Mol Hepatol; 2017 Dec; 23(4):265-272. PubMed ID: 29113030
[TBL] [Abstract][Full Text] [Related]
10. Transarterial Chemoembolization Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma (IDADOX): Protocol for a Randomized, Non-inferiority, Double-Blind Trial.
Choi JW; Kim HC; Han J; Jang MJ; Chung JW
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):372-378. PubMed ID: 38147153
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Drug-eluting Beads Transarterial Chemoembolization for Unresectable Gastric Carcinoma.
Bi Y; Ren J; Han X
J Gastrointest Surg; 2023 Nov; 27(11):2577-2579. PubMed ID: 37407896
[No Abstract] [Full Text] [Related]
12. Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives.
Welker MW; Trojan J
World J Gastroenterol; 2011 Jul; 17(26):3075-81. PubMed ID: 21912449
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Pe J; Choi B; Choi H; Kwon SW; Kim DH
Cardiovasc Intervent Radiol; 2022 Dec; 45(12):1834-1841. PubMed ID: 35962212
[TBL] [Abstract][Full Text] [Related]
14. Discussing the safety and effectiveness of transcatheter arterial embolization combined with intravenous chemotherapy in treating locally advanced breast cancer.
Zhang J; Zhang J; Niu X; Zhou Y; Guo Y; Wang Y; Shou F
Sci Rep; 2024 Mar; 14(1):6003. PubMed ID: 38472493
[TBL] [Abstract][Full Text] [Related]
15. Explosomes: A new modality for DEB-TACE local delivery of sorafenib: In vivo proof of sustained release.
Sakr OS; Zaitoun MMA; Amer MS; Qubisi M; Elshafeey AH; Jordan O; Borchard G
J Control Release; 2023 Dec; 364():12-22. PubMed ID: 37816482
[TBL] [Abstract][Full Text] [Related]
16. Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma.
Krokidis M; Fakitsa D; Malagari K; Karampelas T; Fokas D; Tamvakopoulos C; Chatziioannou A
Cardiovasc Intervent Radiol; 2024 May; 47(5):661-669. PubMed ID: 38609583
[TBL] [Abstract][Full Text] [Related]
17. Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma.
Paul SB; Sharma H
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S112-21. PubMed ID: 25755602
[TBL] [Abstract][Full Text] [Related]
18. Performance and Safety of a Reflux-Control Microcatheter Used to Perform DEB-TACE with LUMI
Angileri SA; Lanza C; Carriero S; Biondetti P; Ascenti V; Pellegrino G; Caruso A; Carrafiello G; Ierardi AM
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892768
[TBL] [Abstract][Full Text] [Related]
19. Clinical research progress of callisperes
Wang Q; Zhu L; Sheng Q
Discov Oncol; 2024 May; 15(1):161. PubMed ID: 38739205
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic factors in patients diagnosed with bladder cancer complicated by hemorrhage treated by drug-eluting bead embolization.
Peng J; Weng Z; Zhang C; Zhou G; Lin Y; Kołat D; Chipollini J; Wu W
Transl Androl Urol; 2023 Nov; 12(11):1697-1707. PubMed ID: 38106678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
